EI
WGS icon

EAM Investors’s GeneDx Holdings WGS Stock Holding History

EAM Investors’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,249
Closed -$3.15M – 385
2025
Q4 		$3.15M Buy
24,249
+5,611
+30% +$770K 0.35% 143
2025
Q3 		$1.98M Buy
+18,638
New +$2.03M 0.23% 160
2025
Q2 		– Sell
-41,446
Closed -$3.67M – 356
2025
Q1 		$3.67M Sell
41,446
-9,737
-19% -$845K 0.63% 59
2024
Q4 		$3.93M Buy
51,183
+18,446
+56% +$1.29M 0.56% 88
2024
Q3 		$1.39M Sell
32,737
-5,968
-15% -$202K 0.21% 143
2024
Q2 		$1.01M Buy
+38,705
New +$734K 0.16% 159

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM Investors's WGS Position: Q1 2026 in Review

EAM Investors sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 24,249 shares — an estimated $3.15M sold.

EAM Investors first reported a position in WGS in Q2 2024 and held it in 6 quarters. The position peaked at $3.93M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • EAM Investors reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • EAM Investors sold 24,249 GeneDx Holdings shares in Q1 2026, an estimated $3.15M.
  • EAM Investors first reported a position in GeneDx Holdings in Q2 2024 and held it in 6 quarters.
  • EAM Investors's GeneDx Holdings position peaked at $3.93M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.